Purkersdorf, Austria

Vera Baumgartl-Strasser

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vera Baumgartl-Strasser: Innovator in Viral Vaccine Development

Introduction

Vera Baumgartl-Strasser is a prominent inventor based in Purkersdorf, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines for viral infections. With a total of three patents to her name, her work focuses on innovative solutions for preventing and treating serious health conditions.

Latest Patents

Among her latest patents, Vera has developed genetically modified arenaviral vectors that serve as vaccines for the prevention and treatment of cytomegalovirus (CMV) infections. These patents include pharmaceutical compositions and methods aimed at addressing CMV infections and reactivation. Additionally, she has worked on immunotherapies for Hepatitis B virus infections, providing genetically modified arenaviral vectors suitable for similar preventive and treatment applications.

Career Highlights

Vera Baumgartl-Strasser is currently associated with Hookipa Biotech GmbH, where she continues to advance her research in viral vaccines. Her innovative approaches have positioned her as a key figure in the biotechnology sector, contributing to the development of effective treatments for viral infections.

Collaborations

Throughout her career, Vera has collaborated with notable professionals in her field, including Thomas P. Monath and Katherine Cohen. These partnerships have enhanced her research and expanded the impact of her work in vaccine development.

Conclusion

Vera Baumgartl-Strasser's contributions to the field of biotechnology, particularly in the development of vaccines for CMV and Hepatitis B, highlight her role as an influential inventor. Her ongoing work at Hookipa Biotech GmbH continues to pave the way for innovative solutions in viral infection treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…